US 11685921
Molecules and agents for treating hepatitis B virus
granted A61KA61K47/6911A61K9/1271
Quick answer
US patent 11685921 (Molecules and agents for treating hepatitis B virus) held by ARCTURUS THERAPEUTICS, INC. expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCTURUS THERAPEUTICS, INC.
- Grant date
- Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K47/6911, A61K9/1271